Probiotics: insights and new opportunities for Clostridioides difficile intervention

被引：17
作者：
Pal, Rusha [1 ]
Athamneh, Ahmad I. M. [2 ]
Deshpande, Riddhi [3 ]
Ramirez, Jose A. R. [4 ]
Adu, Kayode T. [4 ,5 ]
Muthuirulan, Pushpanathan [6 ]
Pawar, Shrikant [7 ]
Biazzo, Manuele [8 ]
Apidianakis, Yiorgos [9 ]
Sundekilde, Ulrik Kraemer [10 ]
de la Fuente-Nunez, Cesar [11 ,12 ,13 ,14 ,15 ]
Martens, Mark G. [3 ,16 ]
Tegos, George P. [16 ]
Seleem, Mohamed N. [1 ,17 ]
机构：
[1] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA
[2] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA
[3] Reading Hosp, Tower Hlth, W Reading, PA USA
[4] James Cook Univ, ProbioWorld Consulting Grp, Townsville, Qld, Australia
[5] La Trobe Univ, Walter & Eliza Hall Inst, Cann Grp, Bundoora, Vic, Australia
[6] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA
[7] Yale Sch Med, Anlyan Ctr, Yale Ctr Genom Anal, New Haven, CT USA
[8] Bioarte Ltd Labs, Life Sci Pk, San Gwann, Malta
[9] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus
[10] Aarhus Univ, Dept Food Sci, Aarhus, Denmark
[11] Univ Penn, Perelman Sch Med, Machine Biol Grp,Inst Translat Med & Therapeut, Inst Biomed Informat,Dept Psychiat, Philadelphia, PA 19104 USA
[12] Univ Penn, Perelman Sch Med, Machine Biol Grp,Inst Translat Med & Therapeut, Inst Biomed Informat,Dept Microbiol, Philadelphia, PA 19104 USA
[13] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA
[14] Univ Penn, Sch Engn & Appl Sci, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA
[15] Univ Penn, Penn Inst Computat Sci, Philadelphia, PA 19104 USA
[16] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[17] Virginia Polytech Inst & State Univ, Ctr Emerging Zoonot & Arthropod Borne Pathogens, Blacksburg, VA 24061 USA
来源：
CRITICAL REVIEWS IN MICROBIOLOGY | 2023年 / 49卷 / 03期
关键词：
Probiotics; C; difficile; inhibition; virulence; immunomodulatory; genomic exploration; discovery informatics; metabolomics; multi-omics; regulatory requirements; ANTIBIOTIC-ASSOCIATED DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; LACTOBACILLUS-ACIDOPHILUS CL1285; INTESTINAL BARRIER FUNCTION; SACCHAROMYCES-BOULARDII; IN-VITRO; DOUBLE-BLIND; FAECALIBACTERIUM-PRAUSNITZII; PRIMARY PREVENTION; ESCHERICHIA-COLI;
D O I：
10.1080/1040841X.2022.2072705
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Clostridioides difficile infection (CDI) is a life-threatening disease caused by the Gram-positive, opportunistic intestinal pathogen C. difficile. Despite the availability of antimicrobial drugs to treat CDI, such as vancomycin, metronidazole, and fidaxomicin, recurrence of infection remains a significant clinical challenge. The use of live commensal microorganisms, or probiotics, is one of the most investigated non-antibiotic therapeutic options to balance gastrointestinal (GI) microbiota and subsequently tackle dysbiosis. In this review, we will discuss major commensal probiotic strains that have the potential to prevent and/or treat CDI and its recurrence, reassess the efficacy of probiotics supplementation as a CDI intervention, delve into lessons learned from probiotic modulation of the immune system, explore avenues like genome-scale metabolic network reconstructions, genome sequencing, and multi-omics to identify novel strains and understand their functionality, and discuss the current regulatory framework, challenges, and future directions.
引用
收藏
页码：414 / 434
页数：21
相关论文
共 193 条
  • [1] Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial
    Allen, Stephen J.
    Wareham, Kathie
    Wang, Duolao
    Bradley, Caroline
    Hutchings, Hayley
    Harris, Wyn
    Dhar, Anjan
    Brown, Helga
    Foden, Alwyn
    Gravenor, Michael B.
    Mack, Dietrich
    [J]. LANCET, 2013, 382 (9900) : 1249 - 1257
  • [2] Scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update)
    Andreoletti, Olivier
    Baggesen, Dorte Lau
    Bolton, Declan
    Butaye, Patrick
    Cook, Paul
    Davies, Robert
    Escamez, Pablo S. Fernandez
    Griffin, John
    Hald, Tine
    Havelaar, Arie
    Koutsoumanis, Kostas
    Lindqvist, Roland
    McLauchlin, James
    Nesbakken, Truls
    Prieto, Miguel
    Ricci, Antonia
    Ru, Giuseppe
    Sanaa, Moez
    Simmons, Marion
    Sofos, John
    Threlfall, John
    [J]. EFSA JOURNAL, 2013, 11 (11)
  • [3] Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
    Antharam, Vijay C.
    Li, Eric C.
    Ishmael, Arif
    Sharma, Anuj
    Mai, Volker
    Rand, Kenneth H.
    Wang, Gary P.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (09) : 2884 - 2892
  • [4] Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings
    Appaneal, Haley J.
    Caffrey, Aisling R.
    Beganovic, Maya
    Avramovic, Sanja
    LaPlante, Kerry L.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (09) : 581 - 590
  • [5] Kefir-isolated Lactococcus lactis subsp lactis inhibits the cytotoxic effect of Clostridium difficile in vitro
    Araceli Bolla, Patricia
    Carasi, Paula
    de los Angeles Serradell, Maria
    Liliana De Antoni, Graciela
    [J]. JOURNAL OF DAIRY RESEARCH, 2013, 80 (01) : 96 - 102
  • [6] Au C, 2019, LACTIC ACID BACTERIA, P631682
  • [7] Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection
    Auclair, Julie
    Frappier, Martin
    Millette, Mathieu
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 : S135 - S143
  • [8] Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis
    Baccouri, Olfa
    Boukerb, Amine Mohamed
    Ben Farhat, Leila
    Zebre, Arthur
    Zimmermann, Kurt
    Domann, Eugen
    Cambronel, Melyssa
    Barreau, Magalie
    Maillot, Olivier
    Rince, Isabelle
    Muller, Cecile
    Marzouki, Mohamed Nejib
    Feuilloley, Marc
    Abidi, Fetid
    Connil, Nathalie
    [J]. FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [9] Bäckhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]
  • [10] Lactobacillus delbrueckii ssp bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells
    Banerjee, Pratik
    Merkel, Glenn J.
    Bhunia, Arun K.
    [J]. GUT PATHOGENS, 2009, 1
12345678910